The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review

Abstract Background Globally, approximately 15% of all babies are born with low birth weight (< 2.5 kg) and ≥ 90% of them are born in low- and middle-income countries. Malaria infection in pregnancy remains a public health concern as it can affect both the mother and the newborn. Notably, it incr...

Full description

Bibliographic Details
Main Authors: Line Bakken, Per Ole Iversen
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Malaria Journal
Subjects:
Online Access:https://doi.org/10.1186/s12936-021-03883-z
_version_ 1819134228662583296
author Line Bakken
Per Ole Iversen
author_facet Line Bakken
Per Ole Iversen
author_sort Line Bakken
collection DOAJ
description Abstract Background Globally, approximately 15% of all babies are born with low birth weight (< 2.5 kg) and ≥ 90% of them are born in low- and middle-income countries. Malaria infection in pregnancy remains a public health concern as it can affect both the mother and the newborn. Notably, it increases the risk of newborns with low birth weight. The World Health Organization (WHO) recommends intermittent preventive treatment with ≥ 3 doses of sulfadoxine-pyrimethamine (SP) during pregnancy in areas with moderate to high malaria transmission in Africa. The aim of this topical review is to give an overview of the impact of malaria infection during pregnancy on low birth weight, with focus on East Africa where malaria is endemic. Methods Eleven studies were selected according to a predefined set of criteria. Results Three studies showed a significant reduction in the prevalence of low birth weight with intermittent preventive treatment with SP, whereas four studies found no significant impact of such treatment on low birth weight. The number of SP doses and compliance to this treatment may in part explain these discrepancies. Pregnant women with frequent symptomatic malaria infection had significantly higher risk of placental malaria. Conclusion The WHO recommendation of ≥ 3 doses of intermittent preventive treatment with SP during pregnancy seem effective in preventing low birth weight, but treatment compliance is a challenge. Malaria prophylaxis is important during pregnancy, especially in endemic areas of malaria, such as East Africa.
first_indexed 2024-12-22T09:59:51Z
format Article
id doaj.art-f623641555e345769e53923f15fae928
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-22T09:59:51Z
publishDate 2021-08-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-f623641555e345769e53923f15fae9282022-12-21T18:30:10ZengBMCMalaria Journal1475-28752021-08-012011910.1186/s12936-021-03883-zThe impact of malaria during pregnancy on low birth weight in East-Africa: a topical reviewLine Bakken0Per Ole Iversen1Department of Nutrition, University of OsloDepartment of Nutrition, University of OsloAbstract Background Globally, approximately 15% of all babies are born with low birth weight (< 2.5 kg) and ≥ 90% of them are born in low- and middle-income countries. Malaria infection in pregnancy remains a public health concern as it can affect both the mother and the newborn. Notably, it increases the risk of newborns with low birth weight. The World Health Organization (WHO) recommends intermittent preventive treatment with ≥ 3 doses of sulfadoxine-pyrimethamine (SP) during pregnancy in areas with moderate to high malaria transmission in Africa. The aim of this topical review is to give an overview of the impact of malaria infection during pregnancy on low birth weight, with focus on East Africa where malaria is endemic. Methods Eleven studies were selected according to a predefined set of criteria. Results Three studies showed a significant reduction in the prevalence of low birth weight with intermittent preventive treatment with SP, whereas four studies found no significant impact of such treatment on low birth weight. The number of SP doses and compliance to this treatment may in part explain these discrepancies. Pregnant women with frequent symptomatic malaria infection had significantly higher risk of placental malaria. Conclusion The WHO recommendation of ≥ 3 doses of intermittent preventive treatment with SP during pregnancy seem effective in preventing low birth weight, but treatment compliance is a challenge. Malaria prophylaxis is important during pregnancy, especially in endemic areas of malaria, such as East Africa.https://doi.org/10.1186/s12936-021-03883-zEast AfricaLow birth weightMalariaPregnancySulfadoxine-pyrimethamine
spellingShingle Line Bakken
Per Ole Iversen
The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
Malaria Journal
East Africa
Low birth weight
Malaria
Pregnancy
Sulfadoxine-pyrimethamine
title The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
title_full The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
title_fullStr The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
title_full_unstemmed The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
title_short The impact of malaria during pregnancy on low birth weight in East-Africa: a topical review
title_sort impact of malaria during pregnancy on low birth weight in east africa a topical review
topic East Africa
Low birth weight
Malaria
Pregnancy
Sulfadoxine-pyrimethamine
url https://doi.org/10.1186/s12936-021-03883-z
work_keys_str_mv AT linebakken theimpactofmalariaduringpregnancyonlowbirthweightineastafricaatopicalreview
AT peroleiversen theimpactofmalariaduringpregnancyonlowbirthweightineastafricaatopicalreview
AT linebakken impactofmalariaduringpregnancyonlowbirthweightineastafricaatopicalreview
AT peroleiversen impactofmalariaduringpregnancyonlowbirthweightineastafricaatopicalreview